Evidence map›Paper›PMID 31320752›Full record

ArticleNature chemical biology2019

Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases.

Matthew Ravalin, Panagiotis Theofilas, Koli Basu, Kwadwo A Opoku-Nsiah, Victoria A Assimon, Daniel Medina-Cleghorn, Yi-Fan Chen, Markus F Bohn, Michelle Arkin, Lea T Grinberg and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Targeting ubiquitination in disease and therapy.Signal transduction and targeted therapy · 2025
    Review
  5. Degrons: defining the rules of protein degradation.Nature reviews. Molecular cell biology · 2025
    Review
  6. Review
  7. Article
  8. Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. DSFworld: A flexible and precise tool to analyze differential scanning fluorimetry data.Protein science : a publication of the Protein Society · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Matthew RavalinDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2998-1933
Panagiotis TheofilasDepartment of Neurology, Memory and Aging Center, University of California at San Francisco, San Francisco, CA, USA.
Koli BasuDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Kwadwo A Opoku-NsiahDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Victoria A AssimonDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Daniel Medina-CleghornDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Yi-Fan ChenDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Markus F BohnDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Michelle ArkinDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA.
Lea T GrinbergDepartment of Neurology, Memory and Aging Center, University of California at San Francisco, San Francisco, CA, USA.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA. Charles.Craik@ucsf.edu.ORCID http://orcid.org/0000-0001-7704-9185
Jason E GestwickiDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA, USA. Jason.Gestwicki@ucsf.edu.ORCID http://orcid.org/0000-0002-6125-3154
University of California, San Francisco · USUniversity Memory and Aging Center · US

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2007 to 2018
$48.8M
X-ray Screening and Rapid Structure DeterminationP50AI150476 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2019 to 2021
$14.4M
Project 3: Autophagy dysfunction and neuronal activity in FTDU54NS100717 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI GAN, LI · 2016 to 2020
$10.8M
Molecular Chaperones and Small MoleculesR01NS059690 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason E Gestwicki · 2008 to 2026
$7.9M
RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Renewable antibodies to secreted proteins and single and multi-pass cell surfaceP41CA196276 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2014 to 2018
$5.8M
Neuropathological changes underlying clinical heterogeneity in Alzheimer diseaseK24AG053435 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRINBERG, LEA TENENHOLZ · 2016 to 2025
$1.8M
Exploration of Molecular Chaperone Complexes During Active Protein TriageR01GM109896 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDREWS, PHILIP C, GESTWICKI, JASON E · 2014 to 2017
$1.1M
The role of cell death pathways in mediating neuronal loss during the earliest stages of Alzheimer diseaseK01AG053433 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI THEOFILAS, PANAGIOTIS · 2017 to 2021
$651k
NCATS NIH HHS UL1 TR001872NCI NIH HHS P41 CA196276NIAID NIH HHS P50 AI150476NIA NIH HHS K01 AG053433NIA NIH HHS K24 AG053435NIGMS NIH HHS P50 GM082250NIGMS NIH HHS R01 GM109896NIGMS NIH HHS T32 GM064337NINDS NIH HHS R01 NS059690NINDS NIH HHS U54 NS100717
6 · The paper itself

Abstract

Protein-protein interactions between E3 ubiquitin ligases and protein termini help shape the proteome. These interactions are sensitive to proteolysis, which alters the ensemble of cellular N and C termini. Here we describe a mechanism wherein caspase activity reveals latent C termini that are then recognized by the E3 ubiquitin ligase CHIP. Using expanded knowledge of CHIP's binding specificity, we predicted hundreds of putative interactions arising from caspase activity. Subsequent validation experiments confirmed that CHIP binds the latent C termini at tau

Indexed as

CaspasesCell Line, TumorCrystallography, X-RayEscherichia coliGene Expression RegulationHumansProtein BindingUbiquitinUbiquitin-Activating EnzymesUbiquitinationUbiquitin-Protein LigasesCaspasesSTUB1 protein, humanUBA1 protein, humanUbiquitinUbiquitin-Activating EnzymesUbiquitin-Protein Ligases

Identifiers

PMID31320752
PMCPMC6693490
OpenAlexW2956696658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.